Regeneron Pharmaceuticals Inc - Grafik, Fiyat ve Haberler (NASDAQ:REGN)

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler Temettüler

Çeyreklik Yıllık

Market Capitalization 64.81 B
Employee 15 K
Founded 1988
CEO Leonard Schleifer
Website www.regeneron.com
Headquarter New York, United States
FIGI BBG000C734W3
Industry Biyoteknoloji

Toplam gelir

Net kar

Temel hisse başına kazanç (Temel EPS)

Toplam borç

Serbest nakit akışı

Nakit ve eşdeğerleri

Fiyat/kazanç oranı

18.61

Fiyat/satışlar oranı

5.84

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

REGN

Financials

Regeneron Pharmaceuticals, Inc. - Common Stock

Haberler

Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound?

Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results

Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?

Here's Why Regeneron (REGN) is a Strong Value Stock

EMA nadir işitme kaybı için Regeneron’un gen tedavisini kabul etti

These Are The Upcoming Catalysts For Crispr Therapeutics Stock (NASDAQ:CRSP)

Regeneron amiloidoz tedavisinde olumlu sonuçlar açıkladı

BAYRY's Kerendia Label Expansion Application Gets Priority Review

Apogee Therapeutics: Targeting Atopic Dermatitis (NASDAQ:APGE)

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry?

Company News for May 19, 2026